01
Chemical and bio-chemical products, preparations and
substances; chemical reagents other than for medical or
veterinary purposes; chemical reagents for laboratory use;
chemical test reagents; diagnostic reagents for in vitro
use; diagnostic reagents and buffers; reagents in kit form;
chemical preparations and substances for use in scientific
analysis and research; preparations and substances for
biological and genetic research; receptors, nuclear
receptors; agonists and anti-agonists; chemogenetic
preparations and substances; ion channel inhibitors;
proteins; peptides and amino acids; in-vivo photo
pharmacology preparations and substances (term considered
linguistically incorrect by the International Bureau - Rule
13 (2) (b) of the Regulations); dyes, labels and stains for
chemical, bio-chemical or molecular analysis (term
considered too vague by the International Bureau - Rule 13
(2) (b) of the Regulations); enzymes and enzymatic
preparations and substances for scientific purposes; stem
cells other than for medical or veterinary purposes
05
Reagents for medical or veterinary purposes; reagents in kit
form; test and testing reagents; in-vivo diagnostic
reagents; laboratory reagents for medical or veterinary use;
reagents for laboratory testing (term considered too vague
by the International Bureau - Rule 13 (2) (b) of the
Regulations); chemical diagnostic reagents; chemical
products or preparations for analysis (term considered too
vague by the International Bureau - Rule 13 (2) (b) of the
Regulations); biological products or preparations for
analysis (term considered too vague by the International
Bureau - Rule 13 (2) (b) of the Regulations); antibodies;
chemical products or preparations for use in radio chemical
analysis (term considered too vague by the International
Bureau - Rule 13 (2) (b) of the Regulations); chemical,
biological or biochemical products or preparations for use
in scientific analysis (term considered too vague by the
International Bureau - Rule 13 (2) (b) of the Regulations);
biochemical preparations or substances for medical,
diagnostic or pharmaceutical use; proteins (term considered
too vague by the International Bureau - Rule 13 (2) (b) of
the Regulations); peptides and amino acids (term considered
too vague by the International Bureau - Rule 13 (2) (b) of
the Regulations); in-vitro photo pharmacology preparations
and substances (term considered linguistically incorrect by
the International Bureau - Rule 13 (2) (b) of the
Regulations); antibiotics; reagents and buffers; medical
dyes, labels and stains (term considered too vague by the
International Bureau - Rule 13 (2) (b) of the Regulations);
enzymes and enzymatic preparations and substances for
medical purposes; stem cells for medical or veterinary
purposes; genome (term considered too vague by the
International Bureau - Rule 13 (2) (b) of the Regulations);
DNA (term considered too vague by the International Bureau -
Rule 13 (2) (b) of the Regulations); antivirals for
pharmaceutical or medical purposes
09
Scientific, research, optical, weighing, measuring,
photographic, testing apparatus and instruments; imaging
apparatus not for medical purposes; DNA chips; software;
medical and scientific software; computer software
applications; downloadable computer software applications;
downloadable electronic publications; downloadable
scientific materials; downloadable educational or teaching
material
41
Education and training services; electronic publications
(not downloadable) (term considered too vague by the
International Bureau - Rule 13 (2) (b) of the Regulations);
online publications (not downloadable) (term considered too
vague by the International Bureau - Rule 13 (2) (b) of the
Regulations); organisation of conferences, seminars or
exhibitions; provision of guides and calculators for
scientific education or training (term considered too vague
by the International Bureau - Rule 13 (2) (b) of the
Regulations); provision of scientific, chemical, biological,
biochemical or life science papers and publications for
education or training and advisory and consultancy services
in connection with all of the aforesaid services (term
considered too vague by the International Bureau - Rule 13
(2) (b) of the Regulations)
42
Advisory and consultancy services relating to scientific
research and development; chemical, pharmacology, biological
and biochemical research and development services;
laboratory research and development services; pharmaceutical
research and development services; chemical, biological and
biochemical analysis services; molecular biology and genetic
research services; chemical, scientific, biological and
biochemical advisory and consultancy services; the provision
of tools and guides for use in scientific, biological and
biochemical research and development and advisory and
consultancy services in connection with all of the aforesaid
services (term considered too vague by the International
Bureau - Rule 13 (2) (b) of the Regulations)